Literature DB >> 16752930

What is drug safety?: celebrating 20 years of the Drug Safety journal.

I Ralph Edwards.   

Abstract

Mesh：

Year:  2006        PMID： 16752930     DOI： 10.2165/00002018-200629060-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  27 in total

Review 1.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).

Authors:  Elliot G Brown
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 3.  Pharmacovigilance of herbal medicines : a UK perspective.

Authors:  Joanne Barnes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Health risks of counterfeit pharmaceuticals.

Authors:  Martijn ten Ham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  The importance of adverse reactions in drug regulation.

Authors:  M N Dukes
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

6.  Improving adverse drug reaction monitoring.

Authors:  J McEwen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

Review 7.  Aspirin and Reye's syndrome. A reappraisal.

Authors:  A M Glen-Bott
Journal:  Med Toxicol       Date:  1987 May-Jun

Review 8.  Techniques of postmarketing surveillance. An overview.

Authors:  J L Carson; B L Strom
Journal:  Med Toxicol       Date:  1986 Jul-Aug

Review 9.  Risk management strategies in the postmarketing period : safety experience with the US and European bosentan surveillance programmes.

Authors:  Eleanor S Segal; Cecile Valette; Laurence Oster; Luc Bouley; Catarina Edfjall; Peter Herrmann; Massimo Raineri; Mary Kempff; Saundra Beacham; Cinda van Lierop
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 10.  Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales.

Authors:  Dianne C Berry; D K Raynor; Peter Knapp; Elisabetta Bersellini
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
View more
  1 in total

1.  Poisons centres and the reporting of adverse drug events: the case for further development.

Authors:  Glyn N Volans; Lakshman Karalliedde; Heather M Wiseman
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.